AIM: To observe the clinical effect of Hexuemingmu tablets for the treatment of subconjunctival hemorrhage, and to seek a treatment which can shorten the course of disease and improve the efficacy.

METHODS: Eighty-two(82 eyes)patients randomly received either Hexuemingmu tablets treatment(n=50 cases)or Vitamin C treatment(n=32 cases). Patients were treated with Hexuemingmu tablets(5 tablets)or Vitamin C(0.2g)by oral drugs(3 times a day)respectively. They were clinical observed.

RESULTS: After 1 month,among 50 patients treated with Hexuemingmu tablets, 40 patients were cured, 7 patients were improved and 3 patients were invalid. The total effective rate was 94%(47/50). While in Vitamin C group, 32 patients were treated, 16 patients were cured, 9 patients were improved, and 7 patients were invalid. The total effective rate was 78%(25/32). There was a significant statistical difference between the two groups(P=0.015<0.05).

CONCLUSION: It is effective, easy and safe to use Hexuemingmu tablets for the treatment of subconjunctival hemorrhage. It is worthy to be popularized in clinical treatment.